Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? (Q34113118)

31 July 2017

Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? (English)

1 reference

31 July 2017

1

Carlo Torti

1 reference

31 July 2017

Emanuele Focà

2

1 reference

31 July 2017

Bruno M Cesana

series ordinal

3

1 reference

31 July 2017

Francois X Lescure

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 December 2011

1 reference

31 July 2017

1 reference

31 July 2017

9

1 reference

31 July 2017

138

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-9-138

31 July 2017

0 references

cites work

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Screening for cognitive impairment in human immunodeficiency virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

HIV infection, inflammation, immunosenescence, and aging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Updated research nosology for HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Effects of alcohol and HIV infection on the central nervous system.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Cocaine opens the blood-brain barrier to HIV-1 invasion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: a prospective study in a real-world setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

HIV-1 infection and cognitive impairment in the cART era: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-9-138

Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Localized cerebral proton MR spectroscopy in HIV infection and AIDS.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273440

Classification criteria for mild cognitive impairment: a population-based validation study

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22204606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-9-138

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference